{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,16]],"date-time":"2026-11-16T04:19:44Z","timestamp":1794802784374,"version":"4.9.1"},"reference-count":53,"publisher":"Oxford University Press (OUP)","issue":"7","license":[{"start":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T00:00:00Z","timestamp":1656806400000},"content-version":"vor","delay-in-days":2,"URL":"https:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2022,7,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>Recurrent urinary tract infections are a common health problem. The only comprehensive synthesis on antibiotic prophylaxis in the last 15 years has been a guideline-embedded meta-analysis. We conducted a systematic review and meta-analysis of randomized controlled trials published up to October 13, 2020, evaluating patients age\u2009\u226512 years with either \u22652 episodes of lower urinary tract infection (UTI) within 6 months or\u2009\u22653 in the past year. Placebo or antibiotics were allowed as comparators. Study quality was low. In the 11 placebo-controlled trials, the risk for developing UTI was 85% lower with prophylaxis in comparison with placebo (risk ratio [RR], 0.15; 95% CI, 0.08\u20130.29). In the 9 head-to-head trials, the efficacy of the antibiotic agents appeared similar: The pooled RR indicated no difference between nitrofurantoin and comparators (RR, 1.01; 95% CI, 0.74\u20131.37), nor trimethoprim (+\/- sulfamethoxazole; RR, 1.34; 95% CI, 0.89\u20132.03) or norfloxacin and comparators (RR, 1.17; 95% CI, 0.43\u20131.70). Studies comparing intermittent (postcoital) with continuous strategies revealed intermittent application to be equally effective.<\/jats:p>","DOI":"10.1093\/ofid\/ofac327","type":"journal-article","created":{"date-parts":[[2022,7,3]],"date-time":"2022-07-03T03:26:32Z","timestamp":1656818792000},"source":"Crossref","is-referenced-by-count":34,"title":["Antibiotics for Preventing Recurrent Urinary Tract Infection: Systematic Review and Meta-analysis"],"prefix":"10.1093","volume":"9","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-1838-9208","authenticated-orcid":false,"given":"Philipp","family":"Jent","sequence":"first","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Julia","family":"Berger","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Annette","family":"Kuhn","sequence":"additional","affiliation":[{"name":"Department of Gynecology, Bern University Hospital, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Barbara W","family":"Trautner","sequence":"additional","affiliation":[{"name":"Center for Innovations in Quality, Effectiveness, and Safety (IQuESt), Michael E. DeBakey Veterans Affairs Medical Center and Section of Health Services Research, Baylor College of Medicine , Houston, Texas , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Andrew","family":"Atkinson","sequence":"additional","affiliation":[{"name":"Department of Infectious Diseases, Bern University Hospital, University of Bern , Bern , Switzerland"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jonas","family":"Marschall","sequence":"additional","affiliation":[{"name":"Division of Infectious Diseases, Department of Internal Medicine, Washington University School of Medicine , St. Louis, Missouri , USA"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2022,7,3]]},"reference":[{"key":"2022072511385444800_ofac327-B1","doi-asserted-by":"publisher","first-page":"509","DOI":"10.1016\/S1047-2797(00)00072-7","article-title":"Urinary tract infection: self-reported incidence and associated costs","volume":"10","author":"Foxman","year":"2000","journal-title":"Ann Epidemiol"},{"key":"2022072511385444800_ofac327-B2","doi-asserted-by":"publisher","first-page":"9","DOI":"10.7326\/0003-4819-135-1-200107030-00004","article-title":"Patient-initiated treatment of uncomplicated recurrent urinary tract infections in young women","volume":"135","author":"Gupta","year":"2001","journal-title":"Ann Intern Med"},{"key":"2022072511385444800_ofac327-B3","doi-asserted-by":"publisher","first-page":"167","DOI":"10.1093\/ageing\/afy195","article-title":"Older men may benefit from antimicrobial prophylaxis for recurrent urinary tract infections","volume":"48","author":"Mody","year":"2019","journal-title":"Age Ageing"},{"key":"2022072511385444800_ofac327-B4","doi-asserted-by":"publisher","first-page":"282","DOI":"10.1097\/JU.0000000000000296","article-title":"Recurrent uncomplicated urinary tract infections in women: AUA\/CUA\/SUFU guideline","volume":"202","author":"Anger","year":"2019","journal-title":"J Urol"},{"key":"2022072511385444800_ofac327-B5","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.cmi.2016.08.003","article-title":"Nitrofurantoin\u2019s efficacy and safety as prophylaxis for urinary tract infections: a systematic review of the literature and meta-analysis of controlled trials","volume":"23","author":"Muller","year":"2017","journal-title":"Clin Microbiol Infect"},{"key":"2022072511385444800_ofac327-B6","doi-asserted-by":"publisher","first-page":"548","DOI":"10.1016\/j.ajog.2016.07.040","article-title":"Nitrofurantoin vs other prophylactic agents in reducing recurrent urinary tract infections in adult women: a systematic review and meta-analysis","volume":"215","author":"Price","year":"2016","journal-title":"Am J Obstet Gynecol"},{"key":"2022072511385444800_ofac327-B7","doi-asserted-by":"publisher","first-page":"1174","DOI":"10.1016\/j.juro.2018.04.088","article-title":"Treatment and prevention of recurrent lower urinary tract infections in women: a rapid review with practice recommendations","volume":"200","author":"Smith","year":"2018","journal-title":"J Urol"},{"key":"2022072511385444800_ofac327-B8","doi-asserted-by":"publisher","first-page":"795","DOI":"10.1007\/s00192-014-2569-5","article-title":"Recurrent urinary tract infections in women","volume":"26","author":"Aydin","year":"2015","journal-title":"Int Urogynecol J"},{"key":"2022072511385444800_ofac327-B9","doi-asserted-by":"crossref","first-page":"f3140","DOI":"10.1136\/bmj.f3140","article-title":"Diagnosis and management of recurrent urinary tract infections in non-pregnant women","volume":"346","author":"Gupta","year":"2013","journal-title":"BMJ"},{"key":"2022072511385444800_ofac327-B10","doi-asserted-by":"publisher","first-page":"1006","DOI":"10.1016\/j.jclinepi.2009.06.005","article-title":"Preferred Reporting Items for Systematic Reviews and Meta-Analyses: the PRISMA statement","volume":"62","author":"Moher","year":"2009","journal-title":"J Clin Epidemiol"},{"key":"2022072511385444800_ofac327-B11","volume-title":"Cochrane Handbook for Systematic Reviews of Interventions","author":"Higgins","year":"2011"},{"key":"2022072511385444800_ofac327-B12","doi-asserted-by":"publisher","first-page":"2598","DOI":"10.1001\/jama.1993.03510210084032","article-title":"Users\u2019 guides to the medical literature. II. How to use an article about therapy or prevention. A. Are the results of the study valid? Evidence-based medicine working group","volume":"270","author":"Guyatt","year":"1993","journal-title":"JAMA"},{"key":"2022072511385444800_ofac327-B13","doi-asserted-by":"publisher","first-page":"770","DOI":"10.7326\/0003-4819-92-6-770","article-title":"Antimicrobial prophylaxis of recurrent urinary tract infections: a double-blind, placebo-controlled trial","volume":"92","author":"Stamm","year":"1980","journal-title":"Ann Intern Med"},{"key":"2022072511385444800_ofac327-B14","doi-asserted-by":"publisher","first-page":"703","DOI":"10.1001\/jama.1990.03450060049027","article-title":"Postcoital antimicrobial prophylaxis for recurrent urinary tract infection. A randomized, double-blind, placebo-controlled trial","volume":"264","author":"Stapleton","year":"1990","journal-title":"JAMA"},{"key":"2022072511385444800_ofac327-B15","doi-asserted-by":"publisher","first-page":"1539","DOI":"10.1002\/sim.1186","article-title":"Quantifying heterogeneity in a meta-analysis","volume":"21","author":"Higgins","year":"2002","journal-title":"Stat Med"},{"key":"2022072511385444800_ofac327-B16","doi-asserted-by":"publisher","first-page":"1046","DOI":"10.1016\/S0895-4356(01)00377-8","article-title":"Funnel plots for detecting bias in meta-analysis: guidelines on choice of axis","volume":"54","author":"Sterne","year":"2001","journal-title":"J Clin Epidemiol"},{"key":"2022072511385444800_ofac327-B17","doi-asserted-by":"crossref","first-page":"629","DOI":"10.1136\/bmj.315.7109.629","article-title":"Bias in meta-analysis detected by a simple, graphical test","volume":"315","author":"Egger","year":"1997","journal-title":"BMJ"},{"key":"2022072511385444800_ofac327-B18","doi-asserted-by":"publisher","first-page":"746","DOI":"10.1002\/sim.2971","article-title":"Arcsine test for publication bias in meta-analyses with binary outcomes","volume":"27","author":"Rucker","year":"2008","journal-title":"Stat Med"},{"key":"2022072511385444800_ofac327-B19","doi-asserted-by":"crossref","first-page":"1574","DOI":"10.1136\/bmj.320.7249.1574","article-title":"Empirical assessment of effect of publication bias on meta-analyses","volume":"320","author":"Sutton","year":"2000","journal-title":"BMJ"},{"key":"2022072511385444800_ofac327-B20","doi-asserted-by":"publisher","first-page":"247","DOI":"10.1093\/biostatistics\/1.3.247","article-title":"Meta-analysis, funnel plots and sensitivity analysis","volume":"1","author":"Copas","year":"2000","journal-title":"Biostatistics"},{"key":"2022072511385444800_ofac327-B21","doi-asserted-by":"publisher","first-page":"251","DOI":"10.1177\/096228020101000402","article-title":"A sensitivity analysis for publication bias in systematic reviews","volume":"10","author":"Copas","year":"2001","journal-title":"Stat Methods Med Res"},{"key":"2022072511385444800_ofac327-B22","first-page":"213","article-title":"Antibioprevention of recurrent cystitis. A randomized double-blind comparative trial of 2 dosages of pefloxacin [in French]","volume":"24","author":"Guibert","year":"1995","journal-title":"Presse Med"},{"key":"2022072511385444800_ofac327-B23","doi-asserted-by":"publisher","first-page":"3","DOI":"10.1007\/BF02552109","article-title":"Nitrofurantoin versus trimethoprim for low-dose long-term prophylaxis in patients with recurrent urinary tract infections. A prospective randomized study","volume":"24","author":"Vahlensieck","year":"1992","journal-title":"Int Urol Nephrol"},{"key":"2022072511385444800_ofac327-B24","doi-asserted-by":"publisher","first-page":"505","DOI":"10.1016\/0090-4295(81)90207-7","article-title":"Cinoxacin for treatment and prevention of recurrent urinary tract infection","volume":"17","author":"Landes","year":"1981","journal-title":"Urology"},{"key":"2022072511385444800_ofac327-B25","first-page":"1173","article-title":"Prulifloxacin vs fosfomycin for prophylaxis in female patients with recurrent UTIs: a non-inferiority trial","volume":"25","author":"Costantini","year":"2014","journal-title":"Int Urogynecol J"},{"key":"2022072511385444800_ofac327-B26","doi-asserted-by":"publisher","first-page":"2641","DOI":"10.1002\/sim.1221","article-title":"A graphical method for exploring heterogeneity in meta-analyses: application to a meta-analysis of 65 trials","volume":"21","author":"Baujat","year":"2002","journal-title":"Stat Med"},{"key":"2022072511385444800_ofac327-B27","doi-asserted-by":"crossref","first-page":"1112","DOI":"10.1016\/S0140-6736(71)91270-0","article-title":"Prevention of urinary-tract infection with low-dose nitrofurantoin","volume":"2","author":"Bailey","year":"1971","journal-title":"Lancet"},{"key":"2022072511385444800_ofac327-B28","first-page":"255","article-title":"Cinoxacin prophylaxis for urinary tract infections in young women: a prospective, randomized, double-blind, placebo-controlled trial","volume":"12","author":"Martens","year":"1995","journal-title":"Adv Therapy"},{"key":"2022072511385444800_ofac327-B29","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1093\/jac\/1.suppl_3.93","article-title":"The use of small doses of cephalexin (125\u2005mg) in the management of recurrent urinary tract infection in women","volume":"1","author":"Gower","year":"1975","journal-title":"J Antimicrob Chemother"},{"key":"2022072511385444800_ofac327-B30","first-page":"43","article-title":"Preventive treatment of recurrent cystitis in women. Double-blind randomized study using cinoxacin and placebo","volume":"36","author":"Martorana","year":"1984","journal-title":"Minerva Urol Nefrol"},{"key":"2022072511385444800_ofac327-B31","doi-asserted-by":"publisher","first-page":"1032","DOI":"10.1128\/AAC.33.7.1032","article-title":"Prospective, randomized, placebo-controlled trial of norfloxacin for the prophylaxis of recurrent urinary tract infection in women","volume":"33","author":"Nicolle","year":"1989","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072511385444800_ofac327-B32","first-page":"420","article-title":"Prevention of recurrent lower urinary tract infections by long-term administration of fosfomycin trometamol. Double blind, randomized, parallel group, placebo controlled study","volume":"55","author":"Rudenko","year":"2005","journal-title":"Arzneimittelforschung"},{"key":"2022072511385444800_ofac327-B33","first-page":"533","article-title":"Low-dose norfloxacin versus placebo for long-term prophylaxis of recurrent uncomplicated urinary tract infection","volume":"6","author":"Rugendorff","year":"1987;","journal-title":"Chemioterapia"},{"key":"2022072511385444800_ofac327-B34","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0022-5347(17)54264-0","article-title":"Prophylactic efficacy of cinoxacin in recurrent urinary tract infection: biological effects on the vaginal and fecal flora","volume":"127","author":"Schaeffer","year":"1982","journal-title":"J Urology"},{"key":"2022072511385444800_ofac327-B35","first-page":"901","article-title":"Comparison of low-dose cinoxacin therapy and placebo in the prevention of recurrent urinary tract infections","volume":"15","author":"Scheckler","year":"1982","journal-title":"J Fam Pract"},{"key":"2022072511385444800_ofac327-B36","first-page":"CD001209","article-title":"Antibiotics for preventing recurrent urinary tract infection in non-pregnant women","volume":"3","author":"Albert","year":"2004","journal-title":"Cochrane Database Syst Rev"},{"key":"2022072511385444800_ofac327-B37","doi-asserted-by":"publisher","first-page":"1128","DOI":"10.1016\/S0022-5347(17)54264-0","article-title":"Prophylactic efficacy of cinoxacin in recurrent urinary tract infection: biologic effects on the vaginal and fecal flora","volume":"127","author":"Schaeffer","year":"1982","journal-title":"J Urol"},{"key":"2022072511385444800_ofac327-B38","doi-asserted-by":"publisher","first-page":"111","DOI":"10.1093\/jac\/16.1.111","article-title":"A clinical comparison between Macrodantin and trimethoprim for prophylaxis in women with recurrent urinary infections","volume":"16","author":"Brumfitt","year":"1985","journal-title":"J Antimicrob Chemother"},{"key":"2022072511385444800_ofac327-B39","first-page":"811","article-title":"Smith GW, al-Wali W. Comparative trial of norfloxacin and macrocrystalline nitrofurantoin (Macrodantin) in the prophylaxis of recurrent urinary tract infection in women","volume":"81","author":"Brumfitt","year":"1991","journal-title":"Q J Med"},{"key":"2022072511385444800_ofac327-B40","doi-asserted-by":"publisher","first-page":"98","DOI":"10.1007\/BF01833874","article-title":"A comparative trial of low dose cefaclor and macrocrystalline nitrofurantoin in the prevention of recurrent urinary tract infection","volume":"23","author":"Brumfitt","year":"1995","journal-title":"Infection"},{"key":"2022072511385444800_ofac327-B41","first-page":"234","article-title":"Macrocrystalline nitrofurantoin versus norfloxacin as treatment and prophylaxis in uncomplicated recurrent urinary tract infection","volume":"48","author":"Nunez","year":"1990","journal-title":"Curr Ther Res Clin Exp"},{"key":"2022072511385444800_ofac327-B42","doi-asserted-by":"publisher","first-page":"1241","DOI":"10.1128\/AAC.35.6.1241","article-title":"Long-term prophylaxis with norfloxacin versus nitrofurantoin in women with recurrent urinary tract infection","volume":"35","author":"Raz","year":"1991","journal-title":"Antimicrob Agents Chemother"},{"key":"2022072511385444800_ofac327-B43","first-page":"669","article-title":"Cinoxacin vs trimethoprim - safety and efficacy in the prophylaxis of uncomplicated urinary tract infections","volume":"14","author":"Seppanen","year":"1988","journal-title":"Drugs Exp Clin Res"},{"key":"2022072511385444800_ofac327-B44","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S0022-5347(01)65087-0","article-title":"Post-intercourse versus daily ciprofloxacin prophylaxis for recurrent urinary tract infections in premenopausal women","volume":"157","author":"Melekos","year":"1997","journal-title":"J Urol"},{"key":"2022072511385444800_ofac327-B45","doi-asserted-by":"publisher","first-page":"2335","DOI":"10.1177\/147323001103900633","article-title":"Effectiveness and safety of patient initiated single-dose versus continuous low-dose antibiotic prophylaxis for recurrent urinary tract infections in postmenopausal women: a randomized controlled study","volume":"39","author":"Zhong","year":"2011","journal-title":"J Int Med Res"},{"key":"2022072511385444800_ofac327-B46","doi-asserted-by":"publisher","first-page":"1239","DOI":"10.1093\/infdis\/157.6.1239","article-title":"Efficacy of five years of continuous, low-dose trimethoprim-sulfamethoxazole prophylaxis for urinary tract infection","volume":"157","author":"Nicolle","year":"1988","journal-title":"J Infect Dis"},{"key":"2022072511385444800_ofac327-B47","doi-asserted-by":"crossref","first-page":"704","DOI":"10.1001\/archinternmed.2012.777","article-title":"Lactobacilli vs antibiotics to prevent urinary tract infections: a randomized, double-blind, noninferiority trial in postmenopausal women","volume":"172","author":"Beerepoot","year":"2012","journal-title":"Arch Intern Med"},{"key":"2022072511385444800_ofac327-B48","doi-asserted-by":"publisher","first-page":"3643","DOI":"10.1038\/s41467-019-11571-5","article-title":"Population dynamics of an Escherichia coli ST131 lineage during recurrent urinary tract infection","volume":"10","author":"Forde","year":"2019","journal-title":"Nat Commun"},{"key":"2022072511385444800_ofac327-B49","doi-asserted-by":"crossref","first-page":"XXX\u2013XX","DOI":"10.1093\/ofid\/ofx180.006","article-title":"Prevention of recurrent acute uncomplicated cystitis by increasing daily water in premenopausal women: a prospective, randomized, controlled study","volume":"4","author":"Hooton","year":"2017","journal-title":"Open Forum Infect Dis"},{"key":"2022072511385444800_ofac327-B50","first-page":"CD005131","article-title":"Oestrogens for preventing recurrent urinary tract infection in postmenopausal women","volume":"2","author":"Perrotta","year":"2008","journal-title":"Cochrane Database Syst Rev"},{"key":"2022072511385444800_ofac327-B51","doi-asserted-by":"crossref","first-page":"e068229","DOI":"10.1136\/bmj-2021-0068229","article-title":"Alternative to prophylactic antibiotics for the treatment of recurrent urinary tract infections in women: multicentre, open label, randomised, non-inferiority trial","volume":"376","author":"Harding","year":"2022","journal-title":"BMJ"},{"key":"2022072511385444800_ofac327-B52","doi-asserted-by":"publisher","first-page":"207","DOI":"10.1016\/S0022-5347(01)62099-8","article-title":"Efficacy and safety of self-start therapy in women with recurrent urinary tract infections","volume":"161","author":"Schaeffer","year":"1999","journal-title":"J Urology"},{"key":"2022072511385444800_ofac327-B53","doi-asserted-by":"publisher","first-page":"302","DOI":"10.7326\/0003-4819-102-3-302","article-title":"Management of recurrent urinary tract infections with patient-administered single-dose therapy","volume":"102","author":"Wong","year":"1985","journal-title":"Ann Intern Med"}],"container-title":["Open Forum Infectious Diseases"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/ofid\/advance-article-pdf\/doi\/10.1093\/ofid\/ofac327\/44385266\/ofac327.pdf","content-type":"application\/pdf","content-version":"am","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/7\/ofac327\/45055861\/ofac327.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/ofid\/article-pdf\/9\/7\/ofac327\/45055861\/ofac327.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,7,25]],"date-time":"2022-07-25T07:39:19Z","timestamp":1658734759000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/ofid\/article\/doi\/10.1093\/ofid\/ofac327\/6628136"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,7,1]]},"references-count":53,"journal-issue":{"issue":"7","published-print":{"date-parts":[[2022,7,4]]}},"URL":"https:\/\/doi.org\/10.1093\/ofid\/ofac327","relation":{},"ISSN":["2328-8957"],"issn-type":[{"value":"2328-8957","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2022,7,1]]},"published":{"date-parts":[[2022,7,1]]},"article-number":"ofac327"}}